1. United States Food and Drug Administration. Draft guidance for industry metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products chemistry, manufacturing, and controls documentation. Silver Spring, MD: United States Food and Drug Administration; 1998.
2. ITFG/IPAC-RS. A response to the draft guidance for industry metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products chemistry, manufacturing, and controls documentation. ITFG/IPAC-RS Collaboration CMC Tests and Methods Technical Team; 2001. p. 34–45. Available from IPAC-RS: https://www.ipacrs.org/. Accessed 22 Apr 2022.
3. Chambers F, De S, Baxter S, Parkinson A, Doub WH, Breakwell I, et al. Plume geometry testing relevance and methodology: an IPAC-RS survey. Respiratory Drug Delivery. 2018;2018(2):437–42.
4. Baxter S, Parkinson A, Myatt B, Sinha B, Doub B, De S, et al. Spray pattern testing relevance and methodology: an IPAC-RS survey. Estoril Portugal: RDD Europe; 2019.
5. United States Food and Drug Administration. Draft guidance for industry: metered dose inhaler (MDI) and dry powder inhaler (DPI) products - quality considerations. Silver Spring, MD: United States Food and Drug Administration. Revised April 2018 [cited 7 Aug. 2019]. Available at https://www.fda.gov/media/70851/download.